BIOMAT Database Logo BIOMAT Database Logo

Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis. 1996

F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Cattedra di Medicina Interna I, Università di Bologna, Italy.

OBJECTIVE The majority of adult patients positive for anti-liver-kidney microsomal antibody are also positive for anti-hepatitis C virus and serum HCV RNA. In these patients the role played by hepatitis C virus infection in the progression of liver damage and its relationship with anti-liver-kidney microsomal antibody are, however, still a matter of debate. METHODS To clarify this point we have compared hepatitis C viremia in sera from 31 hepatitis C virus-related chronic hepatitis patients positive for anti-liver-kidney microsomal antibody with that of 31 patients with hepatitis C virus-related chronic hepatitis without autoantibodies using a newly developed competitive reverse transcription-polymerase chain reaction technique. Reverse transcription-polymerase chain reaction was performed using a synthetic competitor of a length similar to that of wild template (71 bp vs 86 bp). RESULTS The results obtained have been related to hepatitis C virus genotypes. Anti-liver-kidney microsomal antibody/anti-HCV positive patients show a median value of hepatitis C virus genome molecules (626829/ml, range 9780-25651424), significantly lower than anti-liver-kidney microsomal antibody negative/anti-HCV positive patients (10158314/ml, range 101822-67429974) (p < 0.001). No hepatitis C virus genotype was significantly associated with anti-liver-kidney microsomal antibody, although a predominance of genotype 1 (subtypes a and b) has been observed in these patients. CONCLUSIONS Since a low hepatitis C viremia has been observed in anti-liver-kidney microsomal antibody positive patients with disease severity comparable to that of patients without autoantibodies, it is conceivable that in them autoimmune mechanisms may cooperate with viral infection in sustaining disease activity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.
August 1994, Journal of hepatology,
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.
June 2009, Journal of hepatology,
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C.
April 1997, Journal of hepatology,
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Chronic active hepatitis associated with anti-liver-kidney microsome antibody type 1.
January 1988, Arquivos de gastroenterologia,
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Heterogeneity of antigenic sites recognized by anti-liver/kidney microsomal antibody type I in autoimmune hepatitis and chronic hepatitis C.
August 1998, Journal of gastroenterology,
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Anti-liver/kidney microsome-1-positive chronic hepatitis C with type I cryoglobulinemia responding to interferon.
November 1995, Internal medicine (Tokyo, Japan),
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.
February 2003, The Journal of pediatrics,
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis.
May 1998, Gut,
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
September 1995, Gut,
F Giostra, and A Manzin, and M Lenzi, and R Francesconi, and L Solforosi, and P Manotti, and L Muratori, and D Zauli, and M Clementi, and F B Bianchi
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection.
August 2012, Journal of viral hepatitis,
Copied contents to your clipboard!